LICENSE AGREEMENTLicense Agreement • May 10th, 2018 • Puma Biotechnology, Inc. • Pharmaceutical preparations • New York
Puma Biotechnology, Inc., a corporation organized and existing under the laws of Delaware with offices at 10880 Wilshire Blvd Suite 2150, Los Angeles, CA 90024 (“Puma”) and Pint Pharma International SA, a company organised and existing under the laws of Switzerland and having its principal place of business at Route de Chenaux 9, 1091 Bourg-en-Lavaux, Switzerland ("Pint”) have entered into this License Agreement as of March 30, 2018 (the “Effective Date”).
COLLABORATION AND LICENSE AGREEMENTCollaboration and License Agreement • May 10th, 2018 • Puma Biotechnology, Inc. • Pharmaceutical preparations • New York
THIS COLLABORATION AND LICENSE AGREEMENT (this “Agreement”), entered into as of January 30th, 2018 (the “Effective Date”), is entered into by and between CANbridgepharma Limited, a corporation organized and existing under the laws of Hong Kong (“CANbridge”), and Puma Biotechnology, Inc., a corporation organized and existing under the laws of the State of Delaware (“PUMA”).
